FridayAug 16, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Expands Product Roadmap to Bring Power of Quantum to Artificial Intelligence & Machine Learning

Expanded product roadmap to enhance D-Wave’s Leap(TM) quantum cloud service and bring new Quantum AI solutions to market Initiative targets three key development areas: quantum distributions for generative AI, Restricted Boltzmann Machine (“RBM”) architectures, and GPU integration CEO Dr. Alan Baratz emphasizes the potential of annealing quantum computing to transform AI/ML by offering more efficient model training, reduced energy consumption, and faster time-to-solution  D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has announced a significant expansion of its Leap quantum cloud service, targeting advancements in artificial intelligence…

Continue Reading

ThursdayAug 15, 2024 2:40 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Announces Completion of Name Change, Begins Trading Under New Symbol

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM), formerly FSD Pharma Inc., a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has finalized its previously announced name change and consolidation. According to the announcement, the company’s class B subordinate voting shares began trading today under the new ticker symbol QNTM. In addition, the company closed on a nonbrokered private placement and issued four postconsolidation Class A multiple voting shares for $18 per share, resulting in gross proceeds of $72. Xorax Family Trust, a trust of which Quantum BioPharma CEO and cochair Zeeshan Saeed is a beneficiary,…

Continue Reading

ThursdayAug 15, 2024 1:47 pm

QualityStocksNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering

Actuate Therapeutics (NASDAQ: ACTU), a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers, recently announced the closing of its previously announced initial offering. The offering comprised 2,800,000 shares of the company’s common stock at a price of $8.00 per unit to the public, raising a total of $22,400,000 in gross proceeds before deductions. In addition, the company has granted a 30-day option to the underwriters to purchase up to 420,000 additional shares, representing 15% of the shares sold in the offering, solely to cover over-allotments, if any, at the initial…

Continue Reading

ThursdayAug 15, 2024 12:07 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Saxon Capital Group Partner to Bring ‘Groundbreaking’ Solar Glass Technology to Destino Ranch

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced a strategic partnership with Saxon Capital Group Inc. (OTC: SCGX). As part of the partnership, SCGX will utilize and integrate its revolutionary Energy Glass Solar(TM) technology across the entirety of GTVH’s highly anticipated Destino Ranch project. Energy Glass Solar(TM) is a patented, optically clear photovoltaic window system that generates continuous electricity from sunlight, diffused, and ambient light. It is an ideal solution for Destino Ranch, offering numerous advantages. “We are thrilled to partner with Saxon Capital Group to bring their groundbreaking solar glass technology to Destino Ranch. This partnership…

Continue Reading

ThursdayAug 15, 2024 11:51 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter ended June 30, 2024 (“Q2 2024”). The company also discussed the clinical development progress of Berubicin, its lead program, and TPI 287, its recently in-licensed abeotaxane for the treatment of brain malignancies. CNS Pharmaceutical expects to be able to release final topline data from its potentially pivotal trial of Berubicin in the first half of 2025. The trial is evaluating Berubicin in adult patients with…

Continue Reading

ThursdayAug 15, 2024 11:03 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today published its financial results for the second quarter ended June 30, 2024, and provided a business update. Scinai plans to host a webinar to discuss its Q2 2024 results and business update on August 20, 2024, at 11 a.m. EDT/6 p.m. Israel Time. Recent highlights from Q2 2024 included the signing of an agreement to restructure a $29 million bank loan to equity and plans to regain Nasdaq compliance by…

Continue Reading

ThursdayAug 15, 2024 9:45 am

Nightfood Holdings Inc. (NGTF): The Power of Portfolio Diversification

Nightfood is blowing up TikTok with its sleep-friendly cookies for nighttime snackers 2024 has been a transformational year, as Nightfood Holdings diversifies into new markets, including Robots-as-a-service (“RaaS”) Nightfood has acquired Future Hospitality Ventures, providing cutting edge technologies for the hospitality and foodservice industry, and signed a Letter of Intent to acquire CarryOutSupplies.com, a packaging distribution company with sales on the rise after $2 million in 2023 Nightfood Holdings (OTCQB: NGTF) has come a long way since its initial focus on the nighttime snacking market. Recent developments reveal a company actively pursuing diversification and expansion into new and emerging sectors.…

Continue Reading

ThursdayAug 15, 2024 9:00 am

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) Is ‘One to Watch’

Renforth Resources Inc. is a mineral exploration company engaged in the acquisition, exploration and development of mineral properties in Canada The company holds gold and battery mineral resources in Quebec’s mining heartland Renforth Resources in July 2024 resumed exploration on its Parbec Gold Deposit, consisting of a surface soil sampling and prospecting campaign The company in July 2024 received a C$262,500 grant from the Province of Quebec to identify and study the metallurgical characteristics of the Victoria mineralization Renforth Resources (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly…

Continue Reading

WednesdayAug 14, 2024 3:30 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Eyes Expansion into More Lucrative Markets

Golden Triangle Ventures (OTC: GTVH) recently completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. “A complete shipping, logistics and trucking operation, Cargo Management Group will be a key component in providing support for GTVH’s Lavish Entertainment division. With the acquisition completed, Golden Triangle is now focused on facilitating the company’s assumption of full ownership of the logistics operation, brokerage business, licenses and all associated assets… The acquisition of Cargo Management Group brings a time-tested, proven performer into the Golden Triangle community. Cargo Management Group reported close to $3 million in top-line revenue last year,” a…

Continue Reading

WednesdayAug 14, 2024 2:45 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. “The central theme of McEwen’s speech was the urgent need to alter the public’s negative perception of the mining industry. This change, he argued, could be achieved by showcasing the industry’s essential contributions to daily life and modern technologies, particularly those aimed…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered